(MNMD) Mind Medicine - Performance 1.3% in 12m
MNMD performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-7.35%
#37 in Peer-Group
Rel. Strength
38.32%
#4734 in Stock-Universe
Total Return 12m
1.27%
#65 in Peer-Group
Total Return 5y
32.41%
#27 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 9.89 USD |
| 52 Week Low | 4.89 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 58.43 |
| Buy/Sell Signal +-5 | 1.00 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: MNMD (1.3%) vs XBI (-7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.23% | 73% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.1% | -6.38% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
3.91% | -0.97% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.34% | 27.6% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.69% | -7.17% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
18.3% | 43% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.03% | 58.7% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.2% | 28.7% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: MNMD vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for MNMD
| Total Return (including Dividends) | MNMD | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -6.27% | 3.36% | 5.25% |
| 3 Months | 32.04% | 15.73% | 24.13% |
| 12 Months | 1.27% | -7.02% | 14.15% |
| 5 Years | 32.41% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | MNMD | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -75.8% | 4.4% | 81% |
| 3 Months | 76.7% | 78.8% | 96.9% |
| 12 Months | -2% | -85.8% | 44.9% |
| 5 Years | -50% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th35.50 | -9.32% | -10.95% |
| 3 Month | %th65.00 | 14.10% | 6.38% |
| 12 Month | %th68.50 | 8.92% | -11.28% |
| 5 Years | %th86.50 | 74.71% | -37.49% |
FAQs
Does Mind Medicine (MNMD) outperform the market?
Yes,
over the last 12 months MNMD made 1.27%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.02%.
Over the last 3 months MNMD made 32.04%, while XBI made 15.73%.
Performance Comparison MNMD vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
MNMD vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 7.8% | -11.5% | -12.4% | -13% |
| US NASDAQ 100 | QQQ | 8% | -11.6% | -13.1% | -11% |
| German DAX 40 | DAX | 9.9% | -4.9% | -24.6% | -28% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 7.9% | -9.5% | -15.8% | -19% |
| Hongkong Hang Seng | HSI | 8.2% | -12.3% | -31.9% | -37% |
| India NIFTY 50 | INDA | 9.6% | -9.7% | -12.7% | 2% |
| Brasil Bovespa | EWZ | 5.3% | -15.1% | -37.5% | -9% |
MNMD vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 9.1% | -12.2% | -16.6% | -23% |
| Consumer Discretionary | XLY | 8.3% | -9.4% | -4.8% | -17% |
| Consumer Staples | XLP | 7.5% | -6.9% | -14.1% | -8% |
| Energy | XLE | 7.4% | -13.3% | -8.3% | 1% |
| Financial | XLF | 7.1% | -11.4% | -17.3% | -29% |
| Health Care | XLV | 8.3% | -8.4% | -5.1% | 6% |
| Industrial | XLI | 7.7% | -10.5% | -20.3% | -24% |
| Materials | XLB | 5.5% | -10.6% | -16.9% | -5% |
| Real Estate | XLRE | 7.8% | -7.3% | -12.1% | -12% |
| Technology | XLK | 7% | -15% | -14.8% | -10% |
| Utilities | XLU | 8.8% | -8.1% | -15.7% | -22% |
| Aerospace & Defense | XAR | 9.9% | -13.3% | -31% | -48% |
| Biotech | XBI | 6.8% | -9.6% | 0.8% | 8% |
| Homebuilder | XHB | 5.3% | -13.3% | -5.3% | -4% |
| Retail | XRT | 5.2% | -11.3% | -8.1% | -10% |
MNMD vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 6.9% | -14.7% | -4.03% | 9% |
| Natural Gas | UNG | 17.3% | 3.6% | 4.4% | 4% |
| Gold | GLD | 7.5% | -5.1% | -33.1% | -38% |
| Silver | SLV | 6.7% | -13.2% | -29.8% | -16% |
| Copper | CPER | 8.7% | -10.9% | -29.5% | -10% |
MNMD vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 9.6% | -7.3% | -9% | 3% |
| iShares High Yield Corp. Bond | HYG | 9% | -7.9% | -11.3% | -9% |